Dimension Capital

Stately Bio specializes in regenerative medicine technologies for therapeutic discovery and manufacturing. Its patented machine learning-based live-cell imaging system measures cell identity, behavior, and maturation directly from live cells without labels or dyes, facilitating non-invasive, real-time analysis of living cells.

Achira, a biotechnology company, specializes in accelerating drug discovery by combining artificial intelligence and physics-based simulations. It develops high-fidelity, scalable models for molecular dynamics, generating synthetic data to enhance drug discovery processes. By addressing the scarcity and high cost of drug discovery data, Achira's atomistic foundation simulation models enable clients to identify and develop therapeutic compounds more efficiently.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.

Automata is an automation company that provides robotic lab automation for the life sciences to accelerate innovation, diagnosis, and discovery at scale. It develops simple, affordable robots and accompanying software designed to work beside humans, enabling researchers and professionals to scale lab workflows, reconfigure tasks, and access automation across laboratories, classrooms, or production lines from anywhere and on any device.

NewLimit focuses on developing epigenetic reprogramming medicines to treat age-related diseases and extend the human health span. It uses single-cell genomics, machine learning, and functional assays to identify epigenetic targets and develop messenger RNA-based therapies for improving metabolic function in liver cells.

Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.

Enveda is a biotechnology company that uses AI-powered tools to explore and characterize molecules from living organisms. It aims to accelerate drug discovery by developing a comprehensive database of chemical biodiversity.

Kaleidoscope is a collaborative, cloud-based research platform for organizing and tracking scientific activities.

Lamin develops open data platforms for computational biology. It offers data application programming interfaces (APIs) that employ machine learning algorithms to provide data management services, collaborative workspaces, and learning platforms for research and development in the biotechnology industry.

NewLimit focuses on developing epigenetic reprogramming medicines to treat age-related diseases and extend the human health span. It uses single-cell genomics, machine learning, and functional assays to identify epigenetic targets and develop messenger RNA-based therapies for improving metabolic function in liver cells.

Verisian is a technology company that specializes in accelerating drug development and approval processes. It offers a data platform designed for health professionals, which enhances trial integrity and traceability, enabling real-time analysis and monitoring of studies. This platform ultimately helps to bring safe and effective therapies to patients faster by streamlining the drug testing and FDA approval process.